Skip to Content

High-Price Drugs

Our Position

Everyone should be able to get the medications they need at a cost they can afford. But drug prices are out of control, and hardworking families feel the consequences every day. It’s time to hold pharmaceutical companies accountable for the prices that they, and they alone, set and increase year after year.

Health insurance providers fight against high prices for more affordable medications for Americans. We do not have to choose between innovation and affordability. With the right solutions, Americans can have both.




2024 Medicare, Medicaid, Duals & Commercial Markets Forum

Mar 12 - 14, 2024
Learn More


Your Compliance Roadmap for the CMS Prior Authorization Rule

Mar 6, 2024 • 1:00 – 2:00 pm EST
Learn More


Building Member Trust & Loyalty through Community-Based Social Support Groups

Mar 5, 2024 • 2:00 – 3:00 pm EST
Learn More


Getting the Facts: Drug Companies Increasingly Using Patent Games to Avoid Competition

A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.

New Health Affairs Study: Competition In Pharmaceuticals Leads to Lower Prices, Reduced Drug Spending

A study published in Health Affairs found that new brand-name pharmaceutical competition resulted in decreases in net prices of existing drugs.

AHIP State Contacts

Find contact information for AHIP state affairs staff and view state-specific resources.

View States